Psychiatry might need some psychedelic therapy.

The article discusses some of the controversies over psychedelic drugs in managing a variety of psychiatric disorders. The discovery of lysergic acid diethyamide, or LSD, was said to be a strong contributor to the neuroscientific model that took hold in the 1950s and 1960s. Some investigators in Europe and the U.S. re-initiated human studies with psychedelics during the 1990s. It is noted that the mechanisms underlying psychedelic efficacy might be biological and psychological.